Anic Equity¶
'#---------------------------------------------------------#'
Total return since start: 0.708 %¶
'#---------------------------------------------------------#'
Equity now: -----------------------------> 52176.17 Kr¶
Max Equity ever reached: ------------> 53120.35 Kr¶
Portfolio value: --------------------------> 45841.14 Kr¶
PnL: ---------------------------------------> -911.86 Kr¶
DD now: ---------------------------------> -1.777 %¶
Max portfolio DD since start: ----> -13.025 %¶
Updated:¶
'2023-06-13 12:34:17.875589'
Anic Portfolio Holdings¶
| volume | changePercent | value | profit | profitPercent | acquiredValue | |
|---|---|---|---|---|---|---|
| name | ||||||
| Nederman Holding | 11 | 3.400000 | 2343.000000 | 154.000000 | 7.040000 | 2189.000000 |
| Embracer Group B | 26 | 2.510000 | 690.950000 | 28.950000 | 4.370000 | 661.999988 |
| SynAct Pharma | 9 | -0.800000 | 668.700000 | 23.700000 | 3.670000 | 645.000003 |
| Biotage | 4 | 0.520000 | 621.600000 | 18.600000 | 3.080000 | 603.000000 |
| Sdiptech B | 3 | 1.300000 | 840.000000 | 18.000000 | 2.190000 | 822.000000 |
| Vitrolife | 3 | 2.580000 | 693.000000 | 16.000000 | 2.360000 | 677.000001 |
| BHG Group | 49 | -6.050000 | 654.640000 | 15.640000 | 2.450000 | 638.999984 |
| Addtech B | 3 | 1.540000 | 714.000000 | 14.000000 | 2.000000 | 699.999999 |
| Eastnine | 6 | -2.960000 | 669.600000 | 12.600000 | 1.920000 | 657.000000 |
| Xvivo Perfusion | 3 | 0.000000 | 856.500000 | 11.500000 | 1.360000 | 845.000001 |
| Indutrade | 5 | 1.490000 | 1330.000000 | 10.000000 | 0.760000 | 1320.000000 |
| Addnode Group B | 6 | 1.520000 | 760.800000 | 8.800000 | 1.170000 | 751.999998 |
| Nolato B | 12 | -0.460000 | 655.200000 | 7.200000 | 1.110000 | 648.000000 |
| Latour B | 2 | 2.200000 | 455.800000 | 6.800000 | 1.510000 | 449.000000 |
| BONESUPPORT HOLDING | 10 | -0.410000 | 1228.000000 | 4.000000 | 0.330000 | 1224.000000 |
| Fortnox | 10 | 3.680000 | 670.800000 | 2.800000 | 0.420000 | 668.000000 |
| NCC A | 6 | 1.840000 | 598.800000 | -0.200000 | -0.030000 | 598.999998 |
| NCC B | 7 | -0.960000 | 652.400000 | -1.600000 | -0.240000 | 653.999997 |
| Profoto Holding | 7 | -0.240000 | 579.600000 | -2.400000 | -0.410000 | 581.999999 |
| Lime Technologies | 2 | -0.670000 | 590.000000 | -3.000000 | -0.510000 | 593.000000 |
| Sampo Oyj SDB | 1 | -0.600000 | 499.000000 | -6.000000 | -1.190000 | 505.000000 |
| Volati | 5 | -4.720000 | 565.000000 | -9.000000 | -1.570000 | 574.000000 |
| Investor B | 3 | 0.280000 | 647.400000 | -10.600000 | -1.610000 | 657.999999 |
| SCA A | 4 | -0.680000 | 586.400000 | -12.600000 | -2.100000 | 599.000000 |
| Humana | 40 | 1.740000 | 654.400000 | -19.600000 | -2.910000 | 674.000000 |
| Sedana Medical | 135 | -2.860000 | 4303.800000 | -27.200000 | -0.630000 | 4330.999935 |
| Balco Group | 39 | -1.360000 | 1834.950000 | -40.050000 | -2.140000 | 1874.999997 |
| Ambea | 68 | 0.940000 | 2482.000000 | -55.000000 | -2.170000 | 2537.000032 |
| Lundin Gold | 7 | 0.770000 | 917.000000 | -57.000000 | -5.850000 | 973.999999 |
| Creades A | 7 | 1.030000 | 547.400000 | -63.600000 | -10.410000 | 610.999998 |
| Investor A | 16 | 0.140000 | 3460.800000 | -84.200000 | -2.380000 | 3545.000000 |
| New Wave B | 40 | -0.810000 | 3788.000000 | -128.000000 | -3.270000 | 3916.000000 |
| Gaming Innovation Group | 161 | 0.400000 | 4057.200000 | -130.800000 | -3.120000 | 4187.999942 |
| Wästbygg Gruppen B | 80 | -2.350000 | 2664.000000 | -207.000000 | -7.210000 | 2871.000000 |
| Bactiguard Holding B | 37 | -3.760000 | 2560.400000 | -406.600000 | -13.700000 | 2966.999993 |
| TOTAL | 45841.140000 | -911.860000 | -1.77744% | 46752.999863 |
Updated:¶
'2023-06-13 12:34:35.790393'
None
Last optimization/rebalancing:¶
'2023-05-05'
Next optimization/rebalancing:¶
'2023-06-15'
AVAN-Live vs backtest and OMXSE30 2023¶
Walk forward test results - depending on starting day¶
Equity is shown as log of returns. Returns range by a factor of 10. Best is about 10000%, 100 times money, and worst 1000%, 10 times money in 20 years. Maximal duration for drawdown periods vary between 280-750 days. Worst drawdown across the tests is about 40 %. ¶
